Form D · Biotechnology

Alpheus Medical, Inc.

Chanhassen, MN · CIK 0001716636

Offering snapshot reported Jul 30, 2026 · SEC filing

Reported sold
$60.5M
Offering amount: $67M
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 2, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$30.2M$60.5MMay 19, 2025: $34,527,457.00May 19, 2025Jul 30, 2026: $60,477,409.00Jul 30, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$34,527,457 → $60,477,409

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 30, 2026Amendment$60,477,409$25,949,952vs May 19, 202522SEC filing
May 19, 2025Initial$34,527,457No comparison22SEC filing
Nov 9, 2022Initial$13,999,995No comparison4SEC filing
Dec 23, 2020Initial$6,000,000No comparison23SEC filing
May 1, 2020Amendment$519,000$469,000vs Oct 15, 201912SEC filing
Oct 15, 2019Initial$50,000No comparison2SEC filing
Oct 29, 2018Amendment$1,284,005$641,132vs May 2, 201822SEC filing
May 2, 2018Initial$642,873No comparison5SEC filing
Mar 28, 2018Amendment$150,000$50,000vs Jan 25, 20182SEC filing
Jan 25, 2018Initial$100,000No comparison1SEC filing
Sep 11, 2017Initial$225,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-546462

Source: Form D, filed Jul 30, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Vijay Agarwal Director, Executive
William Davis Executive
Imran Eba Executive
Patrick Gora Executive
John Johnson Director
Terrance Kurtenbach Executive
Jeremy Ling Executive
Juan Pablo Mas Director
Aaron Sandoski Director
Robert Stein Director
Peter Thompson Director
Klaus Veitinger Director
Conrad Wang Director
Steve Weiner Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1266 Park Road
Chanhassen, MN, 55317
Phone: 310-413-4338